EDGE MEDICAL-B Shares Surge Following Inclusion in Hang Seng Composite Index

Stock News05-26

EDGE MEDICAL-B (02675) saw its shares rise sharply in early trading, with gains exceeding 11% at one point. As of the latest update, the stock is up 6.66%, trading at HKD 56.85 with a turnover of HKD 15.29 million.

The movement follows the announcement of the quarterly review results for the Hang Seng Index Series on May 22. EDGE MEDICAL-B has been included in the Hang Seng Composite Index. The changes are scheduled to take effect after the market close on June 5, 2026, and will be implemented starting June 8, 2026. Subsequently, the Shanghai and Shenzhen Stock Exchanges are expected to adjust the scope of eligible stocks for the Southbound Stock Connect program accordingly.

EDGE MEDICAL-B is now a potential candidate for inclusion in the Stock Connect scheme, as it meets a series of criteria including market capitalization and liquidity requirements.

The company is pursuing a global expansion strategy and has established a comprehensive product and technology portfolio. This includes multi-port and single-port laparoscopic surgical robots, a remote surgery system, and a bronchoscopy robot. EDGE MEDICAL-B has launched what it claims is the world's only integrated product combining multi-port, single-port, and remote surgical capabilities. The company continues to explore the application value of surgical robots in areas such as precision minimally invasive surgery, telemedicine, and cross-regional medical collaboration.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1101302584?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-26 10:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1101302584","market":"nz","top_or_hot":-1,"title":"EDGE MEDICAL-B Shares Surge Following Inclusion in Hang Seng Composite Index","media":"Stock News","content":"<p>EDGE MEDICAL-B (02675) saw its shares rise sharply in early trading, with gains exceeding 11% at one point. As of the latest update, the stock is up 6.66%, trading at HKD 56.85 with a turnover of HKD 15.29 million.</p>\n<p>The movement follows the announcement of the quarterly review results for the Hang Seng Index Series on May 22. EDGE MEDICAL-B has been included in the Hang Seng Composite Index. The changes are scheduled to take effect after the market close on June 5, 2026, and will be implemented starting June 8, 2026. Subsequently, the Shanghai and Shenzhen Stock Exchanges are expected to adjust the scope of eligible stocks for the Southbound Stock Connect program accordingly.</p>\n<p>EDGE MEDICAL-B is now a potential candidate for inclusion in the Stock Connect scheme, as it meets a series of criteria including market capitalization and liquidity requirements.</p>\n<p>The company is pursuing a global expansion strategy and has established a comprehensive product and technology portfolio. This includes multi-port and single-port laparoscopic surgical robots, a remote surgery system, and a bronchoscopy robot. EDGE MEDICAL-B has launched what it claims is the world's only integrated product combining multi-port, single-port, and remote surgical capabilities. The company continues to explore the application value of surgical robots in areas such as precision minimally invasive surgery, telemedicine, and cross-regional medical collaboration.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EDGE MEDICAL-B Shares Surge Following Inclusion in Hang Seng Composite Index</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEDGE MEDICAL-B Shares Surge Following Inclusion in Hang Seng Composite Index\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-26 10:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>EDGE MEDICAL-B (02675) saw its shares rise sharply in early trading, with gains exceeding 11% at one point. As of the latest update, the stock is up 6.66%, trading at HKD 56.85 with a turnover of HKD 15.29 million.</p>\n<p>The movement follows the announcement of the quarterly review results for the Hang Seng Index Series on May 22. EDGE MEDICAL-B has been included in the Hang Seng Composite Index. The changes are scheduled to take effect after the market close on June 5, 2026, and will be implemented starting June 8, 2026. Subsequently, the Shanghai and Shenzhen Stock Exchanges are expected to adjust the scope of eligible stocks for the Southbound Stock Connect program accordingly.</p>\n<p>EDGE MEDICAL-B is now a potential candidate for inclusion in the Stock Connect scheme, as it meets a series of criteria including market capitalization and liquidity requirements.</p>\n<p>The company is pursuing a global expansion strategy and has established a comprehensive product and technology portfolio. This includes multi-port and single-port laparoscopic surgical robots, a remote surgery system, and a bronchoscopy robot. EDGE MEDICAL-B has launched what it claims is the world's only integrated product combining multi-port, single-port, and remote surgical capabilities. The company continues to explore the application value of surgical robots in areas such as precision minimally invasive surgery, telemedicine, and cross-regional medical collaboration.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSCI","symbol_name":"恒生综合指数","start_time":0,"source_url":"","article_id":"1101302584","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1101302584","pubTimestamp":1779762029,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"EDGE MEDICAL-B (02675) saw its shares rise sharply in early trading, with gains exceeding 11% at one point. As of the latest update, the stock is up 6.66%, trading at HKD 56.85 with a turnover of HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HSCI":"恒生综合指数","BK1100":"医疗保健设备","BK4585":"ETF&股票定投概念","BK4588":"碎股","02675":"精锋医疗-B","VXUS":"国际股票ETF-Vanguard"},"translate_title":"EDGE MEDICAL-B股纳入恒生综合指数后飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02675":1,"VXUS":1,"HSCI":1},"content_text":"EDGE MEDICAL-B (02675) saw its shares rise sharply in early trading, with gains exceeding 11% at one point. As of the latest update, the stock is up 6.66%, trading at HKD 56.85 with a turnover of HKD 15.29 million.\nThe movement follows the announcement of the quarterly review results for the Hang Seng Index Series on May 22. EDGE MEDICAL-B has been included in the Hang Seng Composite Index. The changes are scheduled to take effect after the market close on June 5, 2026, and will be implemented starting June 8, 2026. Subsequently, the Shanghai and Shenzhen Stock Exchanges are expected to adjust the scope of eligible stocks for the Southbound Stock Connect program accordingly.\nEDGE MEDICAL-B is now a potential candidate for inclusion in the Stock Connect scheme, as it meets a series of criteria including market capitalization and liquidity requirements.\nThe company is pursuing a global expansion strategy and has established a comprehensive product and technology portfolio. This includes multi-port and single-port laparoscopic surgical robots, a remote surgery system, and a bronchoscopy robot. EDGE MEDICAL-B has launched what it claims is the world's only integrated product combining multi-port, single-port, and remote surgical capabilities. The company continues to explore the application value of surgical robots in areas such as precision minimally invasive surgery, telemedicine, and cross-regional medical collaboration.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1101302584","isCrawlerRequest":true}